How to Incorporate New Tyrosine Kinase Inhibitors in the Treatment of Patients With Medullary Thyroid Cancer

Journal of Clinical Oncology - United States
doi 10.1200/jco.2013.51.5098
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Tyrosine Kinase Inhibitors in Advanced Thyroid Cancer

Journal of the Siena Academy of Sciences
2012English

Tyrosine Kinase Inhibitors for the Treatment of Thyroid Cancer: Present and Future

Endocrinology&Metabolism International Journal
2015English

Renal Dysfunction in Patients With Radioactive Iodine-Refractory Thyroid Cancer Treated With Tyrosine Kinase Inhibitors

Medicine
Medicine
2019English

Elucidating the Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer Patients

Canadian Journal of Biotechnology
2017English

Tyrosine Kinase Inhibitors: A Foe for the Thyroid?

Journal of Endocrinology and Thyroid Research
2017English

Tyrosine Kinase Inhibitors in Lung Cancer

Hematology/Oncology Clinics of North America
OncologyHematology
2012English

ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: Thyroid Effects of Tyrosine Kinase Inhibitors

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2014English

Invasive Aspergillosis Complicating Treatment With Tyrosine Kinase Inhibitors

BMJ Case Reports
Medicine
2019English

Cardiotoxicity Monitoring in Patients Treated With Tyrosine Kinase Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy